EXCELSIA, INC.: QCOM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXCELSIA, INC. on QCOM, newest first. How the timeline and the estimate are built.
EXCELSIA, INC. held 0 QCOM shares at 2014-12-31 per its 13F-HR filed 2015-01-20.
the latest 13F is the newest step
- period ended2014-12-3113F 0 sharesChange vs previous 13F -17,876 shares
13F-HR 0001372365-15-000001 filed by EXCELSIA, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2014-09-3013F 17,876 sharesChange vs previous 13F -741 shares
2.21% of the 13F portfolio, value $1,337,000.
13F-HR 0001372365-14-000005 filed by EXCELSIA, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2014-06-3013F 18,617 sharesChange vs previous 13F -19,410 shares
1.89% of the 13F portfolio, value $1,474,000.
13F-HR 0001372365-14-000003 filed by EXCELSIA, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2014-03-3113F 38,027 sharesChange vs previous 13F -6,275 shares
4.16% of the 13F portfolio, value $2,999,000.
13F-HR 0001372365-14-000002 filed by EXCELSIA, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2013-12-3113F 44,302 sharesChange vs previous 13F -22,115 shares
4.54% of the 13F portfolio, value $3,289,000.
13F-HR 0001372365-14-000001 filed by EXCELSIA, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2013-09-3013F 66,417 sharesChange vs previous 13F not available
4.82% of the 13F portfolio, value $4,471,000.
13F-HR 0001372365-13-000004 filed by EXCELSIA, INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).